Navigation Links
ADVENTRX Pharmaceuticals Reports Second Quarter Financial Results
Date:8/12/2009

armaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company whose product candidates are designed to improve the safety of existing cancer treatments. More information can be found on the Company's website at www.adventrx.com.

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to submit an NDA for ANX-530, to fund operations or pre-launch activities during the FDA review period if an NDA is submitted or launch activities should an NDA for ANX-530 be approved; the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to continue as a going concern; the risk that ADVENTRX will seek protection under the provisions of the U.S. Bankruptcy Code; the risk that ADVENTRX will reassess the results of the ANX-530 bioequivalence study and determine to conduct additional bioequivalence studies of ANX-530, including in humans; the potential for regulatory authorities to require additional preclinical work and/or clinical activities to support regulatory filings, including prior to the submission or the approval of an NDA for ANX-530, which activities may increase the cost and timeline to NDA submission or approval; the risk the FDA will determine that ANX-530 and Navelbine(R) are not bioequivalent, including as a result of performing pharmacokinetic equivale
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference
4. ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA
5. ADVENTRX Pharmaceuticals to Present at the ThinkEquity Partners Fifth Annual Growth Conference
6. ADVENTRX Pharmaceuticals to Present at the 2007 UBS Global Life Sciences Conference
7. ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference
8. ADVENTRX Pharmaceuticals to Present at the 2007 BIOInvestor Forum
9. ADVENTRX Appoints Vice President of Commercialization
10. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
11. ADVENTRX Announces Consolidation of Clinical and Management Positions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... Burlington, MA (PRWEB) November 13, 2014 ... today announced they were named one of the Boston ... among the Medium Sized Businesses in Massachusetts to receive ... Work’ honors employers who take care of their most ... The awards are presented annually, and are based on ...
(Date:11/15/2014)... 2014 Tapping into the human genome’s ... already proven itself as a viable market with multiple ... this opportunity with its current service offerings; its ... genealogical history for a nominal fee and provided sample. ... service and forthcoming myDNA Fitness program offer ...
(Date:11/15/2014)... Biofuels will present at CleanEquity Monaco 2015 on March 5th ... . Logo - http://photos.prnewswire.com/prnh/20141114/158674LOGO ... by Innovator Capital, the London based ... Prince Albert II of Monaco,s ... Monte-Carlo SBM, Oceanographic Museum of Monaco , ...
(Date:11/12/2014)... 12. November 2014  Fluke Biomedical, ... weltweit führend in der Entwicklung und ... und Simulationen und diagnostische Bildgebung. ... Nach dem erfolgreichen Zusammenschluss im ... in Hinsicht auf Produktqualität, erstklassigen Service ...
Breaking Biology Technology:Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2DNA Spectrum Begins the Search For a New Chief Executive Officer 2DNA Spectrum Begins the Search For a New Chief Executive Officer 3Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 2Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 3Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 4Fluke Biomedical/Unfors RaySafe rüstet sich für Wachstum in EMEA-Region 5
... at Sanford-Burnham Medical Research Institute (Sanford-Burnham) and the Medical ... botulinum neurotoxin, a potential bioterrorism agent, survives the hostile ... human body. Their study, published February 24 in ... neurotoxin together with its bodyguard, a protein made simultaneously ...
... such as thistles, buttercups and clover could be critical ... according to Researchers funded by the Biotechnology and Biological ... Science , researchers from the University of Bristol detail ... commonly found on farms throughout the UK and the ...
... create are stunning. Others are not mismatched fonts, poorly ... A deluge of data presents a challenge to amateur designers, ... the figure,s main message. A group of University of Washington ... and those in design. The new Design Help Desk, similar ...
Cached Biology Technology:Disarming the botulinum neurotoxin 2Disarming the botulinum neurotoxin 3Farm 'weeds' have crucial role in sustainable agriculture 2Design eye for the science guy: Drop-in clinic helps scientists communicate data 2Design eye for the science guy: Drop-in clinic helps scientists communicate data 3
(Date:11/11/2014)... -- Forensicon, Inc., a Chicago -based digital ... promotion of Yaniv Schiff from Senior Computer ... new role as Director, he will lead company efforts ... and provide leadership within the company,s digital forensics practice ... Schiff joined Forensicon in 2006 and ...
(Date:11/7/2014)... Calif. , Nov. 7, 2014  In conjunction with ... Police Departments, The Community Foundation of the Verdugos ... DNA JUSTICE PROJECT," a $250,000 initiative to keep ... initial phase. In its first six months of existence, the ... needed evidence support for local law enforcement. "Because ...
(Date:11/6/2014)... deaths occur because of metastasis, yet progress in ... slow. , "It,s been particularly challenging to design ... research fellow in systems biology at Harvard Medical ... until after they,ve already metastasized." , Gujral and ... should help researchers better understand how metastasis begins. ...
Breaking Biology News(10 mins):Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2Migration negation 2Migration negation 3
... Columbia University Mailman School of Public Health examined the ... mass index (BMI) and obesity in New York City ... outlets is associated with a lower BMI and lower ... -- although far more abundant than healthy ones -- ...
... Blindness in millions of people with diseases that starve ... with a procedure being developed by researchers at Oak ... the University of Tennessee. The technique uses a ... to retinal tissue being deprived of oxygen because of ...
... 2009 (BRONX, NY) Researchers from the Albert ... have developed an onsite method to quickly diagnose tuberculosis ... mingle undetected with treatable TB strains. This study ... peer-reviewed online journal from the Public Library of Science. ...
Cached Biology News:Differences in neighborhood food environment may contribute to disparities in obesity 2ORNL, Southern Cal set sights on preventing blindness 2Einstein and Pitt researchers develop new TB test that will dramatically cut diagnosis time 2
... Cell Dissociation Buffers are membrane-filtered isotonic ... chelating agents and cell-conditioning agents in ... salt solution or Ca2+- and ... of mammalian cells from support substrates ...
Request Info...
Mouse monoclonal [7A6] to NFAT2 ( Abpromise for all tested applications). entrezGeneID: 4772 SwissProtID: O95644...
Attoglow Western Blot Enhancing Kit contains Millennium Enhancer which can significantly boost Western blot signals, and is compatible with other enhancing mechanisms to achieve multiplied enhancing ...
Biology Products: